Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,420.00
Bid: 1,150.00
Ask: 1,065.00
Change: 0.00 (0.00%)
Spread: -85.00 (-7.391%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,420.00
PSN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

8 Jan 2009 07:00

RNS Number : 2994L
Persimmon PLC
08 January 2009
 



TRADING UPDATE - 8 JANUARY 2009

Persimmon plc announces the following trading update ahead of its Preliminary Results for the year ended 31 December 2008, which will be announced on Tuesday 3 March 2009.

Results for the full year will be in line with market expectations. We have legally completed 10,202 units at an average selling price of c. £172,000. This represents a turnover of c. £1.76 billion.

Our emphasis on cash control has resulted in a reduction of total borrowings at the year end to c. £600 million (June 2008: £906 million). As anticipated at the time of our Interim Results on 21 August 2008 we have generated good net cash inflow from operations through the second half of 2008. Close control of work in progress including the focus on sales of stock properties and over 50% reduction in part exchange holdings has resulted in this strong cash generation, despite the previously reported deterioration in trading conditions encountered from early September 2008. The year end borrowings are lower than originally anticipated due to the early receipt of tax repayment following the provisions announced in our Interim Management Statement on 27 October 2008.

Until there is an improvement in the restricted credit conditions currently experienced we will continue to focus on conserving cash. As a consequence the Board does not intend to pay a final dividend this year.

In addition, we have commenced discussions for the planned refinancing of the Group's credit facilities. Having made good progress, our bank syndicate and private placement investors are actively engaged in establishing facilities appropriate for the future needs of the business together with covenants reflective of current credit market conditions.

Whilst we believe that the long term future for the UK housing market remains good, the short term outlook is challenging. However, we currently have forward sales of c. £400 million.

Further details of the Group's performance for the year together with a general market update will be provided with the announcement of our Results for the year ended 31 December 2008, on Tuesday 3 March 2009.

For further information, please contact:

Persimmon plc

Mike Farley, Group Chief Executive

Mike Killoran, Group Finance Director

On 8 January 2009 +44 (0) 207 153 1533

Thereafter: +44 (0) 1904 642 199 

M: Communications

Edward Orlebar:  +44 (0) 207 153 1523 / +44 (0) 7738 724 630

Charlotte McMullen:  +44 (0) 207 153 1549 / +44 (0) 7921 881 800

Marylene Guernier  +44 (0) 207 153 1269 / +44 (0) 7776 303 788

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBRMRTMMIMBFL
Date   Source Headline
3rd Jun 202412:33 pmRNSBlock listing Interim Review
3rd Jun 202411:08 amRNSTotal Voting Rights
23rd May 20247:00 amRNSConfirmation of CFO start date
1st May 20241:11 pmRNSTotal Voting Rights
30th Apr 20242:03 pmRNSDirectorate Change
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review
1st Dec 20234:45 pmRNSTotal Voting Rights
17th Nov 202310:25 amRNSHolding(s) in Company
8th Nov 20237:00 amRNSAppointment of Chief Financial Officer
7th Nov 20237:00 amRNSQ3 Trading Statement
3rd Nov 20231:15 pmRNSHolding(s) in Company
1st Sep 20231:15 pmRNSTotal Voting Rights
10th Aug 20237:04 amRNSHalf Year Results
27th Jul 202310:13 amRNSDirectorate Change
10th Jul 20239:27 amRNSDirector Declaration
3rd Jul 20232:46 pmRNSTotal Voting Rights
1st Jun 20234:38 pmRNSTR-1: Notification of major holdings
1st Jun 20231:07 pmRNSBlock listing Interim Review
1st Jun 202311:06 amRNSTotal Voting Rights
3rd May 20235:00 pmRNSHolding(s) in Company
3rd May 20234:12 pmRNSDirector/PDMR Shareholding
2nd May 202311:13 amRNSTotal Voting Rights
26th Apr 20234:32 pmRNSResult of AGM
26th Apr 20237:00 amRNSQ1 Trading Statement
3rd Apr 20234:01 pmRNSDirector/PDMR Shareholding
3rd Apr 20233:05 pmRNSTotal Voting Rights
27th Mar 20233:44 pmRNSDirector/PDMR Shareholding
22nd Mar 20233:00 pmRNSAnnual Report 2022 and Notice of AGM 2023
13th Mar 20231:57 pmRNSDirectorate Change
13th Mar 202312:19 pmRNSUK Government Self Remediation Contract Signed
7th Mar 20235:33 pmRNSHolding(s) in Company
7th Mar 20237:04 amRNSDirector Declaration
6th Mar 20235:02 pmRNSHolding(s) in Company
1st Mar 20237:00 amRNSFull Year Results
12th Jan 20237:00 amRNSTrading Statement
1st Dec 20225:30 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Dec 20225:25 pmRNSVoting Rights and Capital
8th Nov 20227:00 amRNSTrading Statement
1st Nov 20221:00 pmRNSTotal Voting Rights
1st Nov 20229:24 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.